Pursuant to the District of Columbia’s prescription drug marketing cost reporting law [D.C. CODE § 48-833.01], manufacturers and labelers of prescription drugs that employ, direct, or utilize marketing representatives in D.C. are required to submit an annual report disclosing certain prescription drug marketing costs. The report must be submitted to the D.C. Department of Health (Department) by July 1st of each year for those expenses incurred during the previous calendar year.

The Department recently released the "Pharmaceutical Marketing Expenditures in the District of Columbia, 2012" Report ("Report"). According to the Report, 147 pharmaceutical manufacturers and labelers reported expending $97.5 million in 2012 for advertising, gift, and aggregate expenses in D.C. Of this total, companies reported $61.5 million for aggregate expenses, $30.5 million for gift expenses, and $5.4 million for advertising expenses. The report also notes that 15 companies each reported spending over $1 million in total aggregate expenditures, which represented 63.3% of total reported aggregate expenditures.

Click here to view the full report.